Canadian cannabis company Aurora Cannabis Inc. has announced its entry into the lucrative U.S. market with its acquisition of Massachusetts-based Reliva LLC, a seller of hemp-derived cannabidiol or CBD products.
Under the terms of the deal, Aurora will pay about $40 million of its common shares to members of Reliva. The transaction includes a potential payment by Aurora up to an additional $45 million over the next two years upon Reliva achieving certain financial targets. The additional payment will be in Aurora shares, cash or a combination of both.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com